UPDATE 2-Lonza sees growth on pharma outsourcing
October 28, 2011 at 03:32 AM EDT
ZURICH, Oct 28 (Reuters) - Swiss drugs industry supplier Lonza is set to grow underlying sales and operating profit this year despite the strong Swiss franc as it benefits from robust demand from pharmaceutical groups, particularly at a plant in China.
